Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
Best Practice & Research. Clinical Haematology|August 4, 2024
Is HLA-E with its receptors an immune checkpoint or an antigenic determinant in allo-HCT?Hana Rohn, Vera RebmannFrontiers in Immunology|April 11, 2018
The Inner and Outer Qualities of Extracellular Vesicles for Translational Purposes in Breast CancerEsther Schwich, Vera RebmannSeminars in Cancer Biology|August 11, 2007
HLA-G expression in malignant melanomaVera Rebmann, Stefan Wagner, Hans Grosse-WildeSeminars in Cancer Biology|January 8, 2004
Secretion of sHLA-G molecules in malignanciesVera Rebmann, Jens Regel, Dietmar Stolke, et al.Human Immunology|November 7, 2003
Detection of HLA-G5 secreting cellsVera Rebmann, Annika Busemann, Monica Lindemann, et al.Seminars in Cancer Biology|August 9, 2007
HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implicationsVera Rebmann, Holger Nückel, Ulrich Dührsen, et al.International Journal of Cancer|July 19, 2002
Soluble HLA-DR is a potent predictive indicator of disease progression in serum from early-stage melanoma patientsVera Rebmann, Selma Ugurel, Wolfgang Tilgen, et al.Journal of Immunology Research|August 22, 2014
HLA-G as a tolerogenic molecule in transplantation and pregnancyVera Rebmann, Fabiola da Silva Nardi, Bettina Wagner, et al.American Journal of Obstetrics and Gynecology|February 20, 2003
Soluble HLA-DR levels in the maternal circulation of normal and pathologic pregnancyAndrea Steinborn, Vera Rebmann, Alexander Scharf, et al.Blood|October 7, 2004
HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemiaHolger Nückel, Vera Rebmann, Jan Dürig, et al.Pageof 9